We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Anavex Life Sciences Corporation | NASDAQ:AVXL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 1.47% | 3.44 | 3.38 | 3.84 | 3.48 | 3.37 | 3.40 | 949,972 | 00:48:08 |
ANAVEX LIFE SCIENCES CORP.
|
(Name of Issuer)
|
COMMON STOCK, $0.001 PAR VALUE PER SHARE
|
(Title of Class of Securities)
|
032797300
|
(CUSIP Number)
|
February 1, 2017
|
(Date of Event Which Requires Filing of this Statement)
|
CUSIP No.
032797300
|
(1)
Names of Reporting Persons
Park West Asset Management LLC
|
(
2
)
Check the Appropriate Box if a Member of a Group (See Instructions)
|
(a) ☐
(b) ☐
|
(3)
SEC Use Only
|
(4)
Citizenship or Place of Organization
Delaware
|
Number of Shares Beneficially Owned by
Each Reporting Person With:
|
(5) Sole Voting Power
|
2,115,135 *
|
(6) Shared Voting Power
|
0
|
|
(7) Sole Dispositive Power
|
2,115,135 *
|
|
(8) Shared Dispositive Power
|
0
|
(9)
Aggregate Amount Beneficially Owned by Each Reporting Person
2,115,135 *
|
(10)
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions): ☐
|
(
11
)
Percent of Class Represented by Amount in Row (9)
5.3%*
|
(12)
Type of Reporting Person (See Instructions)
IA
|
CUSIP No.
032797300
|
(1)
Names of Reporting Persons
Peter S. Park
|
(
2
)
Check the Appropriate Box if a Member of a Group (See Instructions)
|
(a) ☐
(b) ☐
|
(3)
SEC Use Only
|
(4)
Citizenship or Place of Organization
United States of America
|
Number of Shares Beneficially Owned by
Each Reporting Person With:
|
(5) Sole Voting Power
|
2,115,135 *
|
(6) Shared Voting Power
|
0
|
|
(7) Sole Dispositive Power
|
2,115,135 *
|
|
(8) Shared Dispositive Power
|
0
|
(9)
Aggregate Amount Beneficially Owned by Each Reporting Person
2,115,135 *
|
(10)
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions): ☐
|
(
11
)
Percent of Class Represented by Amount in Row (9)
5.3%*
|
(12)
Type of Reporting Person (See Instructions)
IN
|
Item 1(a). |
Name Of Issuer:
Anavex Life Sciences Corp. (the “Company”)
|
Item 1(b). |
Address of Issuer’s Principal Executive Offices:
|
Item 2(a). |
Name of Person Filing:
|
Item 2(b). |
Address of Principal Business Office or, if None, Residence:
|
Item 2(c). |
Citizenship:
|
Item 2(d). |
Title of Class of Securities:
|
Item 2(e). |
CUSIP No.:
|
Item 3. |
If This Statement Is Filed Pursuant to Rules 13d-1(b) or 13d-2(b) or (c), Check Whether the Person Filing is a:
|
Item 4. |
Ownership:
|
(a)
Amount Beneficially Owned:
|
2,115,135 *
|
(b)
Percent of Class:
|
5.3%*
|
(c)
Number of Shares as to which the person has:
|
|
(i)
sole power to vote or to direct the vote
|
2,115,135 *
|
(ii)
shared power to vote or to direct the vote
|
0
|
(iii)
sole power to dispose or to direct the disposition of
|
2,115,135 *
|
(iv)
shared power to dispose or to direct the disposition of
|
0
|
Item 5. |
Ownership of Five Percent or Less of a Class:
|
Item 6. |
Ownership of More Than Five Percent on Behalf of Another Person:
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
|
Item 8. |
Identification and Classification of Members of the Group:
|
Item 9. |
Notice of Dissolution of Group:
|
Item 10. |
Certification:
|
February 13, 2017
|
||||
PARK WEST ASSET MANAGEMENT LLC
|
||||
By:
|
/s/
|
Grace Jimenez
|
||
Name: Grace Jimenez | ||||
Title: Chief Financial Officer |
/s/
|
Peter S. Park
|
|||
Peter S. Park |
Exhibit
|
Page
|
A. Joint Filing Agreement dated as of February 13, 2017 by and between Park West Asset Management LLC and Peter S. Park
|
9
|
PARK WEST ASSET MANAGEMENT LLC
|
||||
By:
|
/s/
|
Grace Jimenez
|
||
Name: Grace Jimenez | ||||
Title: Chief Financial Officer |
/s/
|
Peter S. Park
|
|||
Peter S. Park |
1 Year Anavex Life Sciences Chart |
1 Month Anavex Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions